Structures by: Haller K. J.
Total: 27
(C28H54N6Co3),(Cl)2,(ClO4)
(C28H54N6Co3),(Cl)2,(ClO4)
Dalton Transactions (2003) 3 279
a=15.315(2)Å b=15.315(2)Å c=13.764(3)Å
α=90° β=90° γ=90°
C16H28FeN8O2,2(Cl4Fe)
C16H28FeN8O2,2(Cl4Fe)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 45 10900-10909
a=9.3413(2)Å b=12.9995(3)Å c=14.4027(4)Å
α=90.00° β=97.4790(10)° γ=90.00°
C42H60FeN12,2(Cl4Fe)
C42H60FeN12,2(Cl4Fe)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 45 10900-10909
a=10.9068(9)Å b=15.8580(11)Å c=16.1047(12)Å
α=89.575(3)° β=89.485(2)° γ=85.889(2)°
C42H60FeN12,2(Cl4In)
C42H60FeN12,2(Cl4In)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 45 10900-10909
a=10.9464(5)Å b=15.9076(7)Å c=16.1604(7)Å
α=89.592(2)° β=89.682(2)° γ=86.288(2)°
C24H36FeN12,2(Cl4In)
C24H36FeN12,2(Cl4In)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 45 10900-10909
a=14.7130(10)Å b=14.7130(10)Å c=37.436(5)Å
α=90.00° β=90.00° γ=120.00°
C24H36FeN12,2(Cl4Fe)
C24H36FeN12,2(Cl4Fe)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 45 10900-10909
a=14.4521(2)Å b=14.4521(2)Å c=36.3458(11)Å
α=90.00° β=90.00° γ=120.00°
C24H36FeN12,2(Cl4Fe)
C24H36FeN12,2(Cl4Fe)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 45 10900-10909
a=14.5996(3)Å b=14.5996(3)Å c=36.9669(18)Å
α=90.00° β=90.00° γ=120.00°
C14H12ClN
C14H12ClN
Acta Crystallographica Section B (1995) 51, 2 187-197
a=5.965(2)Å b=7.423(3)Å c=27.420(3)Å
α=90° β=99.220(10)° γ=90°
C14H12ClN
C14H12ClN
Acta Crystallographica Section B (1995) 51, 2 187-197
a=5.971(2)Å b=7.411(3)Å c=13.731(2)Å
α=90° β=99.130(10)° γ=90°
Catena-tetrakis(imidazole)-tetrakis(μ~2~-oxo)-dioxo-nickel(ii)-di-vanadium
C12H16N8NiO6V2
Acta Crystallographica Section B (2011) 67, 1 41-52
a=16.1379(3)Å b=14.3657(2)Å c=16.3422(4)Å
α=90.00° β=90.1205(9)° γ=90.00°
Catena-tetrakis(imidazole)-tetrakis(μ~2~-oxo)-dioxo-nickel(ii)-di-vanadium
C12H16N8NiO6V2
Acta Crystallographica Section B (2011) 67, 1 41-52
a=16.1988(2)Å b=16.1988(2)Å c=14.5589(2)Å
α=90.00° β=90.00° γ=90.00°
1,10-Phenanthrolin-1-ium (2-Carboxyethyl)(2-carboxylatoethyl)dichlorostannate(IV)
C12H9N21,C6H9Cl2O4Sn11
Acta Crystallographica Section B (2006) 62, 2 255-261
a=7.12040(10)Å b=12.5017(2)Å c=12.5780(2)Å
α=114.4242(11)° β=92.5620(11)° γ=104.3542(12)°
Catena-tetrakis(imidazole)-tetrakis(μ~2~-oxo)-dioxo-manganese(ii)-di-vanadium
C12H16MnN8O6V2
Acta Crystallographica Section B (2011) 67, 1 41-52
a=23.0473(3)Å b=23.0473(3)Å c=29.6521(3)Å
α=90.00° β=90.00° γ=90.00°
Catena-tetrakis(imidazole)-tetrakis(μ~2~-oxo)-dioxo-manganese(ii)-di-vanadium
C12H16MnN8O6V2
Acta Crystallographica Section B (2011) 67, 1 41-52
a=23.0645(3)Å b=23.0645(3)Å c=29.6897(3)Å
α=90.00° β=90.00° γ=90.00°
Catena-tetrakis(imidazole)-tetrakis(μ~2~-oxo)-dioxo-manganese(ii)-di-vanadium
C12H16MnN8O6V2
Acta Crystallographica Section B (2011) 67, 1 41-52
a=16.3615(2)Å b=16.3615(2)Å c=14.8030(2)Å
α=90.00° β=90.00° γ=90.00°
Catena-tetrakis(imidazole)-tetrakis(μ~2~-oxo)-dioxo-cobalt(ii)-di-vanadium
C12H16CoN8O6V2
Acta Crystallographica Section B (2011) 67, 1 41-52
a=22.8863(3)Å b=22.8863(3)Å c=29.2700(3)Å
α=90.00° β=90.00° γ=90.00°
Catena-tetrakis(imidazole)-tetrakis(μ~2~-oxo)-dioxo-cobalt(ii)-di-vanadium
C12H16CoN8O6V2
Acta Crystallographica Section B (2011) 67, 1 41-52
a=22.8606(3)Å b=22.8606(3)Å c=29.2658(3)Å
α=90.00° β=90.00° γ=90.00°
Catena-tetrakis(imidazole)-tetrakis(μ~2~-oxo)-dioxo-cobalt(ii)-di-vanadium
C12H16CoN8O6V2
Acta Crystallographica Section B (2011) 67, 1 41-52
a=16.2666(3)Å b=16.2666(3)Å c=14.6057(2)Å
α=90.00° β=90.00° γ=90.00°
Catena-tetrakis(imidazole)-tetrakis(μ~2~-oxo)-dioxo-cobalt(ii)-di-vanadium
C12H16CoN8O6V2
Acta Crystallographica Section B (2011) 67, 1 41-52
a=16.2544(2)Å b=16.2544(2)Å c=14.5532(2)Å
α=90.00° β=90.00° γ=90.00°
C22H48Cl2N6O8Zn
C22H48Cl2N6O8Zn
Acta Crystallographica Section B (1999) 55, 3 380-388
a=10.191(5)Å b=17.678(8)Å c=17.754(9)Å
α=90.00° β=99.42(2)° γ=90.00°
C22H48Cl2N6NiO8
C22H48Cl2N6NiO8
Acta Crystallographica Section B (1999) 55, 3 380-388
a=10.1770(10)Å b=17.648(2)Å c=17.605(2)Å
α=90.00° β=99.700(10)° γ=90.00°
Iron(III)chlorooctaethylporphyrin
C36H44ClFeN4
Acta Crystallographica Section C (2014) 70, 4 368-374
a=10.4495(3)Å b=10.7805(4)Å c=15.7360(5)Å
α=71.9490(10)° β=73.0340(10)° γ=82.4400(10)°
Tricyclic acyclovir
C11H13N5O3,2(H2O)
Acta Crystallographica Section C (2013) 69, 9 1077-1080
a=8.4500(10)Å b=11.665(2)Å c=14.930(3)Å
α=75.44(2)° β=76.65(2)° γ=86.44(2)°
C24H36FeN12,2(Cl4In)
C24H36FeN12,2(Cl4In)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 45 10900-10909
a=14.6031(3)Å b=14.6031(3)Å c=36.917(2)Å
α=90.00° β=90.00° γ=120.00°
Catena-tetrakis(imidazole)-tetrakis(μ~2~-oxo)-dioxo-manganese(ii)-di-vanadium
C12H16MnN8O6V2
Acta Crystallographica Section B (2011) 67, 1 41-52
a=23.0354(3)Å b=23.0354(3)Å c=29.6005(3)Å
α=90.00° β=90.00° γ=90.00°
Catena-tetrakis(imidazole)-tetrakis(μ~2~-oxo)-dioxo-manganese(ii)-di-vanadium
C12H16MnN8O6V2
Acta Crystallographica Section B (2011) 67, 1 41-52
a=16.3271(2)Å b=16.3271(2)Å c=14.8304(2)Å
α=90.00° β=90.00° γ=90.00°
((C O)6 Fe2) (B3 H7)
C6H7B3Fe2O6
Inorganic Chemistry (1981) 20, 309-313
a=9.006Å b=10.878Å c=12.479Å
α=90° β=99.54° γ=90°